• 1. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 2. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 3. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 4. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 5. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers Phenol ethers
• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers

Introduction to 4-Fluoro-2-(trifluoromethoxy)aniline (CAS No: 123572-66-7)

4-Fluoro-2-(trifluoromethoxy)aniline, with the chemical formula C?H?F?NO, is a fluorinated aromatic amine that has garnered significant attention in the field of pharmaceutical and agrochemical research. This compound, identified by its unique CAS number 123572-66-7, is characterized by the presence of both fluoro and trifluoromethoxy substituents, which contribute to its distinct chemical properties and reactivity. The molecular structure of this compound includes a benzene ring substituted at the 4-position with a fluoro group and at the 2-position with a trifluoromethoxy group, along with an amino group at the 3-position.

The significance of 4-Fluoro-2-(trifluoromethoxy)aniline lies in its potential applications as an intermediate in the synthesis of various bioactive molecules. The fluorine atoms in its structure enhance its lipophilicity and metabolic stability, making it a valuable building block in drug design. Specifically, the trifluoromethoxy group is known to improve binding affinity and selectivity, which are critical factors in the development of pharmaceutical agents.

In recent years, there has been a surge in research focusing on fluorinated compounds due to their favorable pharmacokinetic properties. Studies have demonstrated that fluorine substitution can modulate the pharmacological activity of molecules, leading to improved efficacy and reduced side effects. The incorporation of fluorine atoms into drug candidates has been associated with enhanced binding to biological targets, increased bioavailability, and prolonged half-life. These attributes make compounds like 4-Fluoro-2-(trifluoromethoxy)aniline highly sought after in medicinal chemistry.

One of the most compelling aspects of 4-Fluoro-2-(trifluoromethoxy)aniline is its role as a precursor in the synthesis of active pharmaceutical ingredients (APIs). Researchers have leveraged this compound to develop novel therapeutic agents targeting various diseases. For instance, it has been utilized in the synthesis of kinase inhibitors, which are crucial in treating cancers and inflammatory diseases. The presence of both fluoro and trifluoromethoxy groups allows for further functionalization, enabling chemists to tailor the molecule for specific biological activities.

The chemical reactivity of 4-Fluoro-2-(trifluoromethoxy)aniline is another area of interest. The amino group can participate in various reactions such as nucleophilic aromatic substitution (SNAr), diazotization, and coupling reactions with boronic acids. These reactions are fundamental in constructing more complex molecules and have been widely used in the synthesis of heterocyclic compounds. Additionally, the electron-withdrawing nature of the fluoro and trifluoromethoxy groups can influence the electronic properties of the benzene ring, making it more susceptible to certain types of reactions.

Advances in synthetic methodologies have further enhanced the utility of 4-Fluoro-2-(trifluoromethoxy)aniline. Modern techniques such as palladium-catalyzed cross-coupling reactions have enabled efficient transformations of this compound into more intricate structures. These methods have not only improved yield but also reduced reaction times, making large-scale synthesis more feasible. The development of greener synthetic routes has also been a focus, with efforts to minimize waste and hazardous byproducts.

The pharmacological profile of derivatives derived from 4-Fluoro-2-(trifluoromethoxy)aniline has been extensively studied. Preclinical data suggest that certain analogs exhibit potent activity against disease-causing targets. For example, modifications at the amino group have led to compounds with improved solubility and bioavailability. Furthermore, computational modeling has played a crucial role in understanding how structural changes affect biological activity. These insights have guided researchers in designing more effective drug candidates.

In conclusion, 4-Fluoro-2-(trifluoromethoxy)aniline (CAS No: 123572-66-7) is a versatile intermediate with significant potential in pharmaceutical research. Its unique structural features make it an excellent candidate for synthesizing bioactive molecules with enhanced pharmacological properties. As research continues to uncover new applications for fluorinated compounds, compounds like this will remain at the forefront of drug discovery efforts.

• 847872-12-2(4-amino-3-(trifluoromethoxy)phenol)
• 873055-90-4(4-(Trifluoromethoxy)benzene-1,3-diamine)
• 123572-63-4(5-Fluoro-2-(trifluoromethoxy)aniline)
• 660848-57-7(2-Methoxy-5-(trifluoromethoxy)aniline)
• 917246-34-5(Benzenamine, 2-[3-(trifluoromethoxy)phenoxy]-)
• 452077-64-4(Benzenamine, 2-(trifluoromethoxy)-, hydrochloride)
• 1535-75-7(2-(Trifluoromethoxy)aniline)
• 150361-01-6(Benzenamine, 2-[4-(trifluoromethoxy)phenoxy]-)
• 1352999-96-2(3-fluoro-5-(trifluoromethoxy)aniline)
• 832740-98-4(2-(difluoromethoxy)-4-fluoroaniline)